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Simple Summary: Colorectal cancer (CRC) is the third most diagnosed cancer in men and the second
in women worldwide, being the second most deadly cancer worldwide. The evidence coming from
experimental studies suggest a protective effect of vitamin D intake on the risk of CRC. Different
studies have shown that vitamin D may play a chemopreventive role in colorectal adenoma incidence,
malignant transformation and progression. Our objective was to conduct an updated systematic
review and meta-analysis of both case-control and prospective cohort studies on vitamin D intake
and CRC. This manuscript provides a complete and updated state-of-the-art about vitamin D intake
and CRC risk.
Abstract: Obesity, a sedentary lifestyle, high red meat consumption and alcohol, and tobacco are
considered the driving factors behind colorectal cancer (CRC) worldwide. Both diet and lifestyle
are recognized to play an important role in the prevention of CRC. Forty years later, the vitamin
D–cancer hypothesis is considered consistent. However, the relationship between low vitamin D
intake and CRC is still controversial. The aim of this meta-analysis is to determine the associations
between Vitamin D intake and CRC. MEDLINE-PubMed and Cochrane databases were searched
up to May 2020 for studies evaluating the association between vitamin D intake (from foods and
supplements) and CRC. Two reviewers, working independently, screened all titles and abstracts to
identify the studies that met the inclusion criteria (case-control or prospective cohort (PC) studies
published in English). Data were pooled by the generic inverse variance method using a random or
fixed effect model. Heterogeneity was identified using the Cochran Q-test and quantified by the I2
statistic. A total of 31 original studies were included for the quantitative meta-analysis, comprising a
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total 47.540 cases and 70.567 controls in case-control studies, and a total of 14.676 CRC-incident cases
(out of 808.130 subjects in PC studies) from 17 countries. A significant 25% lower risk was reported
comparing the highest vs. the lowest dietary vitamin D consumption and CRC risk (odds ratio (95%
confidence interval): 0.75 (0.67; 0.85)) in case-control studies, whereas a non-significant association
was reported in case of prospective studies (hazard ratio (95% confidence interval): 0.94 (0.79; 1.11).
The present meta-analysis demonstrates that high dietary vitamin D is associated to CRC prevention.
However, larger and high-quality prospective studies and clinical trials are warranted to confirm this
association.
Keywords: vitamin D intake; meta-analysis; systematic review; colorectal cancer; incidence; case-
control; prospective
1. Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and the
second in women, being the second most deadly cancer worldwide, with about 881,000
deaths estimated for 2018 [1]. Environmental and genetic factors play a major role in the
pathogenesis of CRC. Risk factors for CRC include aging, family history of CRC, medical
history of benign adenomatous polyps and inflammatory bowel diseases, obesity, diabetes,
lack of physical exercise, and diet [2]. The World Cancer Research Fund (WCRF) and
the American Institute for Cancer Research (AICR) has recognized with strong evidence
a decrease in the risk of CRC when consuming wholegrains, foods containing dietary
fiber and dairy products. However, the consumption of high amounts of red and/or
processed meat, and alcoholic drinks have been associated to an increased risk of CRC. The
same institutions have categorized the consumption of fish and low intake of non-starchy
vegetables and fruits with limited suggestive evidence of association with CRC risk. While
it is not clear by which mechanisms this diet modulates cancer risk, there is substantial
metabolic and experimental evidence to implicate fiber and antioxidant micronutrients.
Since Garland et al. [3] in 1980, proposed vitamin D for colon cancer (CC) prevention,
experimental studies with vitamin D have demonstrated evidence for its antitumor effect,
especially in CRC [4]. In vitro and in vivo experiments have suggested a special role of
vitamin D response that may explain the potentially protective effects of vitamin D against
CRC [5,6].
Regarding dietary vitamin D intake, the WCRF/AICR report in 2017 concluded
that the evidence of a protective effect of vitamin D on the risk of CRC was limited
suggestive [7]). A recent meta-analysis of 166 prospective studies published in 2019 showed
that: (1) Colorectal adenoma incidence was inversely correlated with the circulating 25-
hydroxyvitamin D (25(OH)D) level and vitamin D intake; (2) the CRC incidence was
decreased by circulating 25(OH)D and vitamin D intake; (3) high-level circulating 25(OH)D
triggered better CRC-specific survival; and (4) circulating 25(OH)D decreased colorectal
adenoma and CRC risk in populations with higher calcium intake [8]. These results
suggest that vitamin D may play a chemopreventive role in colorectal adenoma incidence,
malignant transformation, and progression to CRC.
Because of this suggestive evidence coming from epidemiologic studies between
dietary vitamin intake and CRC, our objective was to conduct an updated systematic
review and meta-analysis of case-control and prospective cohort (PC) studies on CRC
and vitamin D intake. This article provides a complete and updated state-of-the-art about
vitamin D intake and CRC risk, while considers putative differences coming from sex,
sources of vitamin D (i.e., dietary, supplemental, and total) and was conducted separately
in case-control and PC studies.
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2. Materials and Methods
2.1. Search Strategy and Study Selection
For the present systematic review and meta-analysis, we followed the methodological
guidelines of the Cochrane Handbook for Systematic Reviews of interventions [9] and the
results were reported according to Meta-analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [10]. The present study and the corresponding search protocol have
been registered in the PROSPERO registry (http://www.crd.york.ac.uk/) (accessed on 7
September 2020; ROSPERO) as CRD42020155587.
We conducted a comprehensive electronic systematic search in two databases (Medline
through PUBMED and Cochrane Library) until 5th May 2020 combining different MeSH
terms and key words. PubMed search was conducted using R packages “pubmed.mineR”
and “RISmed”. Table S1 depicts detailed search strategy. Additionally, a manual review
of the reference list from the retrieved articles was conducted to ensure that all relevant
studies conducted in the field were identified.
In the first step, duplicate studies from the identified articles through the search
strategy were discarded. In a second step, two independent reviewers (HB and SC)
performed an initial screening of the titles and abstracts of the retrieved papers against the
eligibility criteria. For that purpose, the Abstrackr (http://abstrackr.cebm.brown.edu/)
(accessed on 7 September 2020) online screening program was used. Their selection was
supervised by PH-A and NB-T.
Eligible studies were those with case-control or with PC design with at least 1-year of
follow-up, conducted on adults (≥18 years old), and reporting the risk estimates as odd
ratios (OR) or hazard ratios (HR) and their corresponding 95% confidence interval (CI)
for the association between vitamin D intake—including dietary, supplements, and/or
total intake and the risk of CRC, CC, and/or rectal cancer (RC). We did not consider for
inclusion published abstracts or proceedings.
2.2. Data Extraction
In order to verify that the articles that passed the previous process met the eligibility
criteria, two independent researchers (HB and SC) reviewed the full text. In addition, they
also extracted relevant information for the systematic review and meta-analysis of each of
the studies using a standardized spreadsheet proforma. Collected data included authors,
journal and year of publication, title of the article, study name, participant characteristics,
sample size, follow-up (only for cohort studies), type of exposure, dietary assessment
method, type of outcome and assessment method, number of cases, statistical analyses,
and multivariable-adjusted risk estimates (OR or HR, and 95%CI) for the association of
interest. Disagreements between researchers were solved by consensus or consulting a
third researcher (PH-A).
2.3. Quality Assessment of the Included Studies
Two different tools were used to assess the quality of the included studies. For case-
control studies, we used The Study Quality Assessment of Case-Control Studies from the
National Heart, Lung, and Blood Institute [11]. It consists of 12 questions that help the
researcher to rate the studies as good, fair, or poor based on details that are reported in the
studies. Poor quality is translated to high risk of bias, and good quality as low risk of bias.
For prospective cohort studies we used the Newcastle-Ottawa Scale [12]. This is
a rating scale ranging from 0 to 9 points that are given to the studies based on three
domains. A maximum of 4, 3, and 2 points are given after evaluating the population
selection, outcome assessment, and comparability domains, respectively. Studies with a
total punctuation of at least 7 points were considered as high quality. Any disagreement
between the researchers (HB and SC) was solved by consensus or consulting a third
researcher (PH-A).
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2.4. Vitamin D Intake and Colorectal Cancer Outcomes
In this meta-analysis we have considered as exposure the intake of vitamin D from
foods (i.e., dietary vitamin D), from supplements (i.e., supplemented vitamin D), and the
composite of the previous two (i.e., total vitamin D intake). Moreover, we considered
the outcomes: CRC and its subsites (i.e., CC and RC). However, the main exposure and
outcome were dietary vitamin D and CRC respectively, in the overall population (i.e., all
subjects). Importantly, results from the same study were included in the meta-analysis
when data were reported by non-overlapping subjects (i.e., men and women to create all
subjects). However, independent meta-analyses were performed for studies comprising
only men, only women, or including both as it has been shown that for CRC and its subsites
the risk is sex-dependent [13].
2.5. Statistical Analyses
We conducted all the analyses using R version 3.6.3 software including packages
“meta” (v. 4.11) and “dmetar” (v. 0.0.9). The natural log-transformed ORs, HRs, and
95% CI comparing highest versus lowest categories of vitamin D intake were pooled
using the generic inverse variance method with fixed-effects model (when less than 5
study comparisons were available) or random-effects model (when at least 5 or more
study comparisons were available). The results were reported back in the original scale.
Studies using continuous risk per dose were excluded from the analyses, but we described
their results within the text. We conducted separated meta-analyses for case-control and
prospective cohort studies.
For all meta-analyses, the Cochran Q statistic was used to estimate inter-study hetero-
geneity and it was quantified by the I2 statistic. We considered substantial heterogeneity
when I2 was ≥ 50% and Pheterogeneity < 0.10. We additionally reported the tau2 as the
estimate of the between-study variance in random-effects meta-analyses.
Sensitivity analyses were conducted when more than four study comparisons (from
independent studies) were available in the analyses by the removal of one study at a time
(i.e., leave-one out approach) from the meta-analyses and recalculating the summary risk
estimates and heterogeneity values. We considered an influential study that changed the
evidence of heterogeneity or the magnitude by more than 20%, the significance and/or
direction of the association. Moreover, the detection of outliers (i.e., study’s confidence
interval does not overlap with the confidence interval of the pooled effect) was also
performed. Finally, a graphic display of heterogeneity (GOSH) plot was performed to test
all the possible study combinations within a meta-analysis (2n − 1 individual analyses,
where “n” is the number of studies) and then plot the pooled effect size on the x-axis and
the between-study heterogeneity at the y-axis.
Publication bias—by means of a funnel plot to visually assess small study effects—is
only possible to be tested when ten or more study comparisons are included in a meta-
analysis [14]. Therefore, we only performed them in the meta-analysis of case-control
studies assessing the risk of CRC by dietary vitamin D intake, in all the subjects.
3. Results
3.1. Study Characteristics
A primary search of MEDLINE-PubMed and Cochrane databases, together with man-
ual search, retrieved a total of 1320 articles (Figure 1) after duplicates were removed. About
96.8% (n = 1278) were excluded based on their title and abstract information according to
the eligibility criteria. Therefore, 42 articles were collected as full texts and were further
assessed for inclusion. A total of 33 articles were included in the qualitative synthesis,
and 31 (which reported risk estimates comparing extreme categories) were included in
quantitative synthesis meta-analysis (Figure 1).
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Figure 1. Flowchart of the studies included in this meta-analysis.
Information regarding each study is depicted in Tables 1 and 2. This meta-analysis
included a total of 47.540 cases and 70.567 controls in case-control studies, and a total of
14.676 CRC-incident subjects (out of 808.130 subjects) in PC studies, from 16 countries
around the world. The follow-up in the PC studies ranged from 5 to 16 years. Most
of the studies assessed vitamin D intake through validated FFQ or using a 24-h dietary
recall. Some studies stratified the analysis by sex. Therefore, we considered these results
separately in each corresponding meta-analysis.
Regarding the quality of the studies, the vast majority of case-control studies were
evaluated as “Good” (81%) and the remaining as “Fair”. All the prospective studies were
qualified a mark at least “7/9”, with 75% of them having a score “8/9”. Estimate risks
from two case-control studies (Peters et al. 1992 [15] and Vallès et al. 2018 [16]) were
only reported on a continuous scale, instead of categories of vitamin D intake (i.e., highest
versus lowest). Moreover, partial data from a case-control study (La Vecchia et al. 1997 [17])
and a PC (Martínez et al. 1996 [18]) were also reported as continuous. These data were not
meta-analyzed but remarked as appropriate.
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Table 1. Characteristics of case-control studies included in the systematic review and meta-analysis (vs.).
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b Dietary 30 to 75 GOOD
a assessed by the Study Quality Assessment Tools from the National Heart, Lung and Blood Institute for case-control studies. b, includes
combined results for men and women, and separated results. c, continuous. d, includes separated results for men and women. e, includes
Denmark, France, Greece, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom. Results from Sun et al. 2011
regarding dietary and total vitamin D are included as the combination of both NL and ON cohorts in Sun et al. 2012. Funding source for
all the studies is agency. Abbreviations: CC, colon cancer; CRC, colorectal cancer; D, decile; EPIC, European Prospective Investigation
Into Cancer and Nutrition; F, females; FFQ, food frequency questionnaire (self-administered); KPMCP, Kaiser Permanente Medical Care
Program of Northern California; M, males; MCC, multicenter case-control; NA, not applicable; NL, Newfoundland and Labrador subjects;
ON, Ontario subjects; Qu, quartile; Q, quintile; RC, rectal cancer; SOCCS, Study of Colorectal Cancer in Scotland; T, tertile; wk, week.
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Table 2. Characteristics of prospective studies included in the systematic review and meta-analysis.
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a, mean, median or range b, assessed by the The Newcastle-Ottawa Scale. c, continuous d, includes combined results for men and women,
and separated results. e, includes separated results for men and women. Abbreviations: CC, colon cancer; CRC, colorectal cancer; F, females;
FFQ, food frequency questionnaire (self-administered); M, males; NA, not applicable; Qu, quartile; Q, quintile; RC, rectal cancer; T, tertile;
wk, week.
3.2. Meta-Analyses of Case-Control Studies
3.2.1. Colorectal Cancer
A total of three independent meta-analyses were performed for case-control studies
assessing the risk of CRC by dietary, supplemental, or total vitamin D intake when consid-
ering all the subjects (Figure 2A). Specifically, a significant 25% lower risk was reported
between dietary vitamin D consumption and CRC risk (OR (95% CI): 0.75 (0.67; 0.85)).
Figure 3 shows the forest plot for that meta-analysis. One study reported this association
separated by sex and significant inverse association was showed in both sexes (Figure 2A).
This significant inverse association was also seen in case of total vitamin D (0.77 (0.66; 0.90);
(forest plot in Figure S1B), whereas it was not significant in case of supplemented vitamin
D (0.86 (0.66; 1.11), forest plot in Figure S1A). In a continuous scale, results from Vallès et al.
2018 [16] showed a non-significant association (0.96 (0.89; 1.03)) between dietary vitamin D
and CRC risk in a population twice represented of men versus women.
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Figure 2. Super plot of (A) case-control and (B) prospective cohort studies assessing the association between vitamin D
intake (highest versus lowest categories) and the risk of colorectal cancer.
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Figure 3. Forest plot for the association between dietary vitamin D intake (highest versus lowest categories) and risk of
colorectal cancer including all subjects for (A) case-control and (B) prospective studies.
3.2.2. Colon Cancer
In Figure 4A we show the results of the case-control studies assessing the association
between vitamin D intake and CC. We found a significant 18% lower risk of CC in those
individuals in the highest versus the lower category of dietary vitamin D intake when
considering all subjects (OR (95% CI): 0.82 (0.67; 0.98)), but not when we separately analyzed
the associations in men or women alone (Figure S2A–C, respectively).
Associations between vitamin D supplementation and CC differed by sex, toward
a significant inverse association for all subjects (0.57 (0.37; 0.88)) and studies conducted
in women (0.74 (0.57; 0.96); Figure S2D,E), but not in case of the unique study in men
(Figure 4A). Finally, total vitamin D was only assessed in one study in women, and showed
a non-significant association in case-control studies (Figure 4A).
In a continuous scale, Peters et al. 1992 [15] reported the associations between CC
and dietary vitamin D in all subjects, men only, and women only, showing non-significant
positive associations in all of them (1.08 (0.97; 1.2); 1.1 (0.95; 1.26); and 1.08 (0.9; 1.28),
respectively). However, La Vecchia et al. 1997 [17] reported a significant inverse association
for all subjects (0.81 (0.70; 0.90)).
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Figure 4. Super plot of (A) case-control and (B) prospective cohort studies assessing the association between vitamin D
intake (highest versus lowest categories) and the risk of colon cancer.
3.2.3. Rectal Cancer
Results specific for RC are summarized in Figure 5. A total of three meta-analyses
reported the association between dietary vitamin D intake and RC risk. We found a
significant and inverse association when considering all the subjects (0.67 (0.51; 0.87))
or women alone (0.57 (0.39; 0.82); Figure S3A,C, respectively), whereas we reported a
non-significant association in men alone (1.03 (0.72; 1.47); Figure S3B). Specific associations
between both supplemental and total vitamin D and RC in women reported non-significant
results (Figure 5A).
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Figure 5. Super plot of (A) case-control and (B) prospective cohort studies assessing the association between vitamin D
intake (highest versus lowest categories) and the risk of rectal cancer.
In a continuous scale, La Vecchia et al. 1997 [17] reported a non-significant association
between dietary vitamin D intake and RC in all subjects (1.03 (0.9; 1.2)).
3.3. Meta-Analyses of Prospective Cohort Studies
3.3.1. Colorectal Cancer
Figure 2B summarized eight meta-analyses and one independent analysis for the
association between dietary intake, supplemental and total vitamin D with CRC incidence
in all subjects, and men or women separately. The main outcome referred to dietary
vitamin D intake in all subjects, and we did not find a significant association (0.94 (0.79;
1.11); Figure 3B). Moreover, we neither reported a significant association between dietary
vitamin D and CRC in men nor in women alone when comparing extreme categories
of dietary vitamin D intake (Figure S1C,D, respectively). In the case of supplemental
vitamin D, we reported a significant inverse association with CRC incidence in all subjects
(0.80 (0.66; 0.96); Figure S1E) and the unique study reporting associations in men (0.65
(0.50; 0.85)), whereas we showed a non-significant association for women (Figure S1F).
Finally, this inverse association was also observed when evaluating total vitamin D, toward
a 20% and 29% protection in case of all subjects (0.80 (0.67; 0.95)) and men (0.71 (0.57;
0.90)), respectively (Figure S1G,H). However, no significant association was reported in the
meta-analysis conducted in women (0.96 (0.81; 1.15); Figure S1I).
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3.3.2. Colon Cancer
Figure 4B shows the super plot of six individual analyses and one meta-analysis for
the prospective association between vitamin D intake and CC incidence.
The only study conducted assessing the association between dietary vitamin D and CC
in all subjects did not show a significant relationship (1.18 (0.40; 3.47)). This non-significant
association was also showed in men and women analyzed separately (Figure S2F). The
analyses assessing the association between either supplemented or total vitamin D in men
or women analyzed separately did not show significant results.
In a continuous scale, Martínez et al. 1996 reported [18], in women only, a non-
significant inverse association for both dietary and total vitamin D intake with CC risk
(0.96 (0.72; 1.28) and 0.81 (0.63; 1.05), respectively).
3.3.3. Rectal Cancer
Only dietary vitamin D intake and the risk of RC has been evaluated in all subjects,
and men or women only. However, in all of them non-significant associations were reported
when comparing extreme categories of intake.
In a continuous scale, Martínez et al. 1996 reported [18], in women only, a significant
association between dietary vitamin D intake and CC risk (0.45 (0.25; 0.83)), and a non-
significant association when total vitamin D was evaluated (1.16 (0.73; 1.82)).
3.4. Meta-Analyses Heterogeneity and Publication Bias
3.4.1. Heterogeneity
We did not find substantial heterogeneity in the meta-analyses of case-control studies
assessing the association between dietary vitamin D and CRC risk in all subjects (I2 = 46%,
p = 0.04; Figure 2A) nor in the meta-analysis of PC studies (I2 = 37%, p > 0.10; Figure 2B).
In the remaining meta-analyses of CRC, we found substantial heterogeneity in case of
both case-control and PC studies evaluating the risk of CRC by supplemental vitamin D
in all subjects (I2 = 71% and 77%, respectively; p < 0.10). In which regards, in colon and
RC independently, we reported substantial heterogeneity in the meta-analyses of case-
control studies assessing the association between dietary vitamin D intake and both colon
(I2 = 55%, p = 0.03) and rectal (I2 = 70%, p < 0.01) cancers in all subjects (Figures 4A and 5A,
respectively). Moreover, we also reported a substantial 61% of heterogeneity (p = 0.07) in
case-control studies assessing the risk of CC by dietary vitamin D intake in women alone
(Figure 4A).
3.4.2. Publication Bias
Publication bias was assessed using the small sample bias method (Borenstein et al.
2011). The best way to visualize whether small studies with small effect sizes are missing is
through funnel plots. Figure S5 shows the funnel plot for the meta-analysis of case-control
studies assessing the association between dietary vitamin D and colorectal cancer in all the
subjects. All studies lied symmetrically around the pooled OR which was confirmed with
a non-significant (p = 0.762) value for the Egger’s test of the intercept.
3.4.3. Sensitivity Analysis
Sensitivity analysis with one study removed at a time (leave-one out approach) was
performed for analyses of more than four studies in order to assess whether the results
could have been substantially affected by a single study. A total of five independent meta-
analyses were tested (Table S2). Importantly, in which regards the analyses of outliers, we
found one outlier in each case-control, dietary vitamin D intake meta-analysis conducted
in all subjects: Levi et al. 2000 [25] in case of CRC (result after its removal: 0.73 (0.66;
0.80)); Kampman et al. 2000 [24] [Men] in case of CC (0.82 (0.67; 0.98)); and Lipworth
et al. 2009 [29] in case of RC (0.67 (0.51; 0.87));Table S2). No outliers were detected in the
prospective cohort meta-analyses.
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In case of case-control studies assessing the association between dietary vitamin D
and CRC in all subjects, we found that the exclusion of Levi et al., Banqué et al., or Zhang
et al. [25,42,46] significantly reduced the heterogeneity (from 46% to 17%, 35% or 23%,
respectively), but had a minimum impact on the pooled OR. In case of case-control studies
evaluating dietary vitamin D association with CC, the removal of Kampman et al. 2000 [24]
[Men] deeply reduced the heterogeneity from 55% to 10%, although still significant, with
an approximately 9% reduction in the OR. The omission of any of the studies did not alter
the high heterogeneity for the association between dietary vitamin D and RC in all subjects
but did modify the pooled OR.
In the meta-analyses of prospective cohort studies assessing the association between
dietary vitamin D and CRC in both all subjects and women alone, no study removal
modified the non-significant pooled HRs. However, in case of the meta-analysis of all
subjects, the removal of Ishihara et al. 2008 [Men], McCullough et al. 2003, or Park et al.
2007 [Men] [45,47,48], changed the non-significant I2 from 7% to a significant 50%.
Interestingly, the GOSH plot for the meta-analysis of case-control studies assessing
the risk of CRC in all subjects by dietary vitamin D intake showed two patterns related
to the inclusion (red color) or exclusion (blue color) of the outlier. In fact, the removal of
the outlier, generated a blue cluster toward reduced pooled ORs with null heterogeneity
(Figure S4A). Figure S4B reports a high dispersion of pooled OR values and extremes
values of heterogeneity (in approximately 60% and 0%) for the meta-analysis of case-
control studies assessing the risk of CC by dietary vitamin D intake in all the subjects.
This value was reduced to 0% heterogeneity and lower pooled OR values after removing
its outlier. A pattern toward protective pooled ORs but with high heterogeneity was
shown in the meta-analysis of case-control studies assessing the risk of RC by dietary
vitamin D intake in all the subjects (Figure S5C). However, the removal of the outlier
reduced the heterogeneity. Figure S4D,E shows the GOSH plots for the meta-analysis
of prospective studies assessing the association between dietary vitamin D intake and
CRC risk in all subjects or women only, respectively. Both plots showed a dispersion of
values around a pooled HR of 1 (i.e., overall estimate of 0)—mirroring its non-significant
associations—although with low heterogeneity.
4. Discussion
The present study is the first meta-analysis and systematic review, conducted sepa-
rately in case-control and PC studies, analyzing the association between vitamin D con-
sumption (including dietary and supplemental vitamin D) and the risk of CRC, CC, and RC,
where the differences between sexes were also considered. In our meta-analysis, regarding
to case-control studies, we found that dietary vitamin D intake was significantly associated
with lower risk of CC, RC, and CRC. A significant association in case of supplemental
vitamin D intake was only observed in CC, whereas in case of total vitamin D a significant
association was observed in case of CRC. In our meta-analysis of prospective studies,
total and supplemental vitamin D intake were solely associated with a reduction in CRC
risk. The findings of the present study suggest that vitamin D consumption may have a
protective role in CRC development, although several considerations must be taken into
account in the management of vitamin D intake and the risk of CRC and the evaluation of
study designs.
Many systematic reviews and meta-analyses have been performed to assess the rela-
tionship between vitamin D intake and CRC risk, although these studies did not distinguish
different vitamin D subtypes, such as total, dietary, or supplemental [8,49,50]. Whereas the
evidence suggests an inverse relationship between CRC risk and vitamin D intake, the con-
clusions are not definitive and point out that additional studies are needed. Indeed, most of
these systematic reviews and meta-analyses were designed using a pool of prospective and
case-control studies, but not separately, which could lead to a misinterpretation of results
due to study designs. So far, only one meta-analysis was performed taking into account
the PC and case-control studies separately. This meta-analysis, conducted by Huncharek
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M et al. 2009 [47], concluded that dietary vitamin D was associated with decreased risk of
CRC/CC only in case-control studies (pooled RR was 0.93 (95% CI, 0.86 to 0.99)), but not in
case of PC studies [47], which was in line with our main finding.
Regarding to meta-analyses with prospective designs conducted in 2011, a previous
meta-analysis also observed an inverse association between CRC risk and dietary vitamin
D intake. However, and differing from our findings, non-significant results were reported
for total vitamin D intake and CRC risk [48], probably because PC studies considering
supplemental vitamin D intake were not included in the risk model of CRC. In contrast, this
study mirrored our data regarding CC and RC risk and dietary vitamin D intake, as a non-
significant association was observed between them [48]. However, another meta-analysis
from nine PC studies found that vitamin D intake (total and dietary) was associated with
decreased risk of CRC [49]. These findings also differed from our results probably because
this study did not include PC studies considering supplemental vitamin D intake.
The first prospective study concerning serum 25(OH)D and the risk of colon cancer
was published by Garland et al. (1989), showing a significant protective role of serum
25(OH)D. Since then, many epidemiological studies have been conducted in both human
and animal models to explore such associations [50]. However, results coming from these
epidemiological studies and additional meta-analyses and systematic reviews have re-
ported either significant inverse associations or non-significant associations in populations
worldwide [49,51,52]. This is because these data did not take into account the additional ad-
justment for cofounding related-variables, such as the design of the studies, sex differences,
tumor site and different metabolites of vitamin D (i.e., 25(OH)D, 1,25(OH)2D), among oth-
ers. As for the supplemental vitamin D in all subjects, our results showed that vitamin D
was related to 20% reduced CRC risk in PC studies and 43% reduced CC risk in case-control
studies. Our results were in line with a meta-analysis which included 17 cohort studies
(including case-control and PC) evaluating the association of vitamin D supplements with
CRC risk, and in which vitamin D supplement intake was related to a decreased risk of
CRC [53]. However, another meta-analysis and systematic review from PC studies did
not find significant associations between vitamin D supplements and CRC [54]. Previous
studies have also been conducted to find the link of VDR polymorphisms in relation to
colorectal cancer. Such polymorphisms are frequently named as BsmI, TaqI, ApaI, Tru9I,
FokI, and PolyA mononucleotide repeat. Accordingly, the meta-analysis conducted by
Touvier et al. (2011) did not observe significant associations between FokI, PolyA, TaqI,
Cdx2, and ApaI VDR polymorphisms and CRC risk, although the BsmI polymorphism
was associated with a lower CRC risk [48]. Additional studies also related FokI polymor-
phism with CRC cases [55,56]. However, these findings require a larger population and a
multivariate analysis of other established risk factors to confirm this association, since it
remains difficult to confirm the association of VDR polymorphisms with CRC.
Taking into consideration the randomized controlled trials (RCTs), it is still unclear
whether supplementation with vitamin D reduces the risk of CRC, since data from RCTs are
limited and only a few RCTs have failed to demonstrate protection on CRC after vitamin D3
supplementation (See Table S3). For instance, in the Women’s Health Initiative (WHI) trial,
no effect was found on CRC prevention after 400 IU of vitamin D3 supplementation [57].
In addition, daily supplementation with high-dose vitamin D (2000 IU/day) for 5 years
(among initially healthy adults in the United States following the VITamin D and OmegA-3
TriaL -VITAL study) did not reduce the incidence of CRC [58]. These inconsistent findings
may be due to confounding factors in the selected studies and longer RCT follow-up in
order to observe the benefits. In addition, CRC was a secondary outcome of the calculation
of the risk of incidence in the RCTs, in which sample size concerning CRC risk was very
limited. Additionally, many of these studies used a relatively small amount of vitamin
D3 and a low follow-up time, up to 7 years. Thus, specific RCTs, which take specific CRC
incidence, large sample size and follow-up time, using high, but safety amount of vitamin
D are necessary.
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The optimal vitamin D intake is a current subject of interest and is essential for clinical
outcome and public health for preventing CRC [59,60]. A previous meta-analysis pointed
out that the daily intake of dietary vitamin D of 160 IU or more was associated with
a reduced risk of CC [61], whereas another quantitative meta-analysis suggested that
daily intake of 1000–2000 IU of vitamin D could reduce the incidence of colorectal with
minimal risk [62]. The 2011 report on dietary reference intakes for vitamin D pointed
to a recommended dietary intake of 600 IU/day for ages 1 to 70 years and 800 IU/day
for ages 71 years and older; higher values were not consistently associated with greater
benefit [63]. As we observed, although accumulating data suggest an inverse association
between higher dietary vitamin D and the risk of CRC, further studies are needed to clarify
the recommended dietary and safety amount of vitamin D to reduce the risk of CRC.
Vitamin D belongs to a group of steroids known as secosteroids. In humans, the
most common forms of vitamin D are vitamin D3 (cholecalciferol) the main dietary form,
and vitamin D2 (ergocalciferol) the form mostly used in supplements and fortified foods.
Furthermore, vitamin D is synthesized on sun exposure, through ultraviolet B (UV-B) radi-
ation, from 7-dehydrocholesterol in the skin [64]. At the cellular level, CRC cells contain
vitamin D receptors (VDR), and express 1-alpha-hydroxylase, and are thus able to convert
25(OH) vitamin D (the metabolite produced in the liver) into the active form of vitamin D
calcitriol (1,25(OH)2D3) [58,63,64]. Activation of these receptors by 1,25(OH)2D induces dif-
ferentiation and inhibits proliferation, invasiveness, angiogenesis, and metastatic potential.
Vitamin D exerts potential roles in CRC and its mechanistic effects additionally showed
several properties in the prevention of CRC. Cell fate and phenotype are strictly regulated
by extracellular signals. The active metabolite of vitamin D, 1,25(OH)2D3, (calcitriol),
inhibits proliferation, induces apoptosis, and promotes epithelial differentiation of human
colon cancer cells, through the modulation of key genes in the carcinogenesis signaling
pathways [5]. In fact, 1,25(OH)2D3, is a major regulator of gene expression and exerts its
effects by binding to a transcription factor of the nuclear receptor superfamily: the vitamin
D receptor (VDR). VDR heterodimerizes with another member of the same family, the
retinoid X receptor, and regulates gene expression in a ligand-dependent manner [4]. For
instance, vitamin D antagonizes the Wnt/βcatenin signaling pathways. An aberrant Wnt
pathway activation is considered a hallmark of CRC. The antiproliferative effect of vitamin
D involves multiple pathways, by inhibiting the cyclin-dependent kinase and growth fac-
tors, as well as by increasing the activity of TGF-β1 (transforming growth factor ß1) [65,66].
Vitamin D is also well-known as a modulator of differentiation in colon carcinoma. It
regulates many genes involved in cell differentiation such as E-cadherin, occludin, and
vinculin, as well as it inhibits β-catenin signaling [67,68]. Furthermore, vitamin D acts by
a variety of mechanistic effect of action to suppress the carcinogenesis process. However,
this effect may depend on the context of action, such as the bioavailability on the specific
tissue and the expression of vitamin D receptor (VDR), as well as the in situ concentration
of vitamin D and the expression of the enzymes such as cytochrome p450 24A1 (CYP24A1)
and 27B1 (CYP27B1), which modulate the active metabolite of vitamin D.
The main strength of the present systematic review and meta-analysis is that it is the
first study analyzing the associations between vitamin D intake, supplemental vitamin D,
and total vitamin D intake in both case-control and PC studies, and considering the sex
of the subjects. In addition, two different databases were used to identify the available
case-control and PC about the relationship between vitamin D intake and supplemental
vitamin D on the CRC risk, in which a few of the additional articles were identified
manually and further added to the analyses. Finally, the research of literature and selected
studies, data selection and extraction, was performed by two independent reviewers, which
guarantee the lack of missing of related publishing data. However, the study also has
several limitations. First, the analysis from case-control studies identified three outliers,
which we have removed from the analysis, reducing the heterogeneity of the results.
Second, the correct assessment of dietary supplement intake in several studies may be
imprecise, being the relationships between vitamin D and colorectal cancer risk partly due
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to unmeasured or residual confounding leading to biased results. Third, we could not
analyze publication bias in a vast majority of the meta-analyses performed since less than
ten study comparisons were included in each one. In addition, for some outcomes we
could not conduct a meta-analysis because only one study was identified. Therefore, future
research is likely to change the observed risk estimates.
5. Conclusions
The quantitative results from our systematic review and meta-analyses from case-
control and PC studies support the idea that both dietary and supplemental intake of
vitamin D are associated with a reduced risk of CRC, which suggests a significant influence
of vitamin D on the prevention of CRC. Available data about vitamin D consumption are
not definitive on CRC risk and additional longer follow-up studies, adjusted by cofounding
variables, such as the nature of study design, exposure of sunlight, type of diet and time
exposure, and amount of supplement vitamin D.
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